Analysis of HLA-DRB1*1501 in Multiple Sclerosis Patients in Khuzestan Province, Iran

Background: Multiple sclerosis (MS) is a demyelinating, autoimmune and neurodegenerative disease of the central nervous system (CNS). The pathogenesis of this disease is still unknown, although there are evidences of environmental factors affecting subjects with genetic predisposition factors. The contribution of HLA-DRB1*1501 to MS risk has been replicated and confirmed in most population-based studies. Since there are no data with respect to the association of HLA-DRB1*1501 and MS in Khuzestan province. Objectives: The aim of this study was to investigate the correlation of this allele with MS in Khuzestan province. Methods: In this case-control study, DRB1*1501 allele was analyzed by polymerase chain reaction with sequence-specific primers (PCR-SSP)in200MSpatientsand200unrelatedhealthyindividuals,withoutanyautoimmunediseasefromthesamegeographical region. The frequencies of the mentioned allele were compared between the patients and control group using SPSS 16 statistical software and the chi square test. Results: Theresultsdemonstratedthatdistributionof DRB1*1501allelewasstatisticallydifferentbetweenpatientandcontrol(41.5% vs. 22.81%, P < 0.001); significant correlation was observed among these allele with both Arab (28.84% vs. 50.84%, P = 0.005) and Persian (15.87% vs. 35.55%, P = 0.018) ethnicities; although no association was revealed between mentioned allele and disease clinical course (relapsing-remitting, secondary-progressive, progressive-relapsing and primary-progressive), expanded disability scale score (EDSS) and gender. Conclusions: Thestudypresentsassociationof susceptibilitytomultiplesclerosisinsouthwestof IranwithHLA-DRB1*1501allelein both Arab and Persian ethnic; although DRB1*1501 may be is not involved in the pathogenesis of different MS disease subtypes. The results are consistent with most of the other studies in Iran; and also most studies in European populations.

[1]  H. Galehdari,et al.  Analysis of HLA-DQB1*0602 in Multiple Sclerosis Patients in Khuzestan Province, Iran. , 2015, Archives of Iranian medicine.

[2]  A. Sayad The association of −330 interleukin‐2 gene polymorphism and HLA‐DR15 allele in Iranian patients with multiple sclerosis , 2014, International journal of immunogenetics.

[3]  Naser Sharafaddinzadeh,et al.  The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs , 2013, Clinical Neurology and Neurosurgery.

[4]  D. Mickevičienė,et al.  The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania , 2013, BMC Neurology.

[5]  G. Moretto,et al.  Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study , 2013, European journal of neurology.

[6]  S. H. Ghaffari,et al.  The influence of the HLA‐DRB1 and HLA‐DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis , 2012, International journal of immunogenetics.

[7]  A. López de Munain,et al.  HLA-DRB1*15:01 and multiple sclerosis: a female association? , 2012, Multiple sclerosis.

[8]  B. Singhal,et al.  HLAA, B, Cw. DRB1 and DQB1 Alleles in Multiple Sclerosis Patients in India , 2012 .

[9]  I. Kouri,et al.  HLA associations with multiple sclerosis in Greece , 2011, Journal of the Neurological Sciences.

[10]  H. Ebadi,et al.  High frequency of the IL-2 -330 T/HLA-DRB1*1501 haplotype in patients with multiple sclerosis. , 2010, Clinical immunology.

[11]  J. Oksenberg,et al.  Opposing effects of the HLA-DRB1*0301-DQB1*0201 haplotype on the risk for multiple sclerosis in diverse Arab populations in Israel , 2010, Genes and Immunity.

[12]  J. Kira,et al.  Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations , 2009, Multiple sclerosis.

[13]  E. Donadi,et al.  HLA-DRB1* allele-associated genetic susceptibility and protection against multiple sclerosis in Brazilian patients. , 2009, Molecular medicine reports.

[14]  P. D. De Jager,et al.  Multiple sclerosis susceptibility alleles in African Americans , 2009, Genes and Immunity.

[15]  M. Pinto-Medel,et al.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain) , 2009, Journal of Neurology.

[16]  T. Kilpatrick,et al.  HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. , 2009, Tissue antigens.

[17]  P. Vermersch,et al.  Is neuromyelitis optica associated with human leukocyte antigen? , 2009, Multiple sclerosis.

[18]  M. Houshmand,et al.  Analysis of HLA DR2&DQ6 (DRB1*1501, DQA1*0102, DQB1*0602) Haplotypes in Iranian Patients with Multiple Sclerosis , 2009, Cellular and Molecular Neurobiology.

[19]  G. Ebers,et al.  Genes for multiple sclerosis , 2008, The Lancet.

[20]  D. Mendonça,et al.  The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population , 2007, Journal of the Neurological Sciences.

[21]  C. Gorodezky,et al.  Mediterranean and Amerindian MHC class II alleles are associated with multiple sclerosis in Mexicans , 2005, Acta neurologica Scandinavica.

[22]  A. Kheradvar,et al.  Optic neuritis, multiple sclerosis and human leukocyte antigen: results of a 4‐year follow‐up study , 2005, European journal of neurology.

[23]  M. Daly,et al.  Genetic analysis of multiple sclerosis. , 2003, Journal of autoimmunity.

[24]  S. Sawcer,et al.  HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[25]  R. Papais-Alvarenga,et al.  DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians. , 1999, Tissue antigens.

[26]  R. Vaughan,et al.  HLA-DR and -DQ associations with multiple sclerosis in Turkey. , 1997, Human immunology.

[27]  A. Mubaidin,et al.  Epidemiology of multiple sclerosis in Arabs in Jordan: a comparative study between Jordanians and Palestinians , 1996, Journal of the Neurological Sciences.

[28]  A. Mubaidin,et al.  Multiple sclerosis in Arabs in Jordan , 1995, Journal of the Neurological Sciences.

[29]  M. A. Kelly,et al.  An investigation of HLA-encoded genetic susceptibility to multiple sclerosis in subjects of Asian Indian and Afro-Caribbean ethnic origin. , 1995, Tissue antigens.

[30]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[31]  W. Mcdonald,et al.  Diagnosis and classification of multiple sclerosis. , 1977, British medical bulletin.